Newborn screening for neuro-metabolic disorders: Strategies, clinical benefits, and prerequisites for program expansion
Newborn screening (NBS) is a successful program of secondary prevention for rare diseases, such as neuro-metabolic diseases, enabling early identification of affected individuals and pre-symptomatic treatment. Driven by innovations in high-throughput sequencing technologies, NBS panels have continue...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 April 2025
|
| In: |
European journal of paediatric neurology
Year: 2025, Jahrgang: 56, Pages: 84-96 |
| ISSN: | 1532-2130 |
| DOI: | 10.1016/j.ejpn.2025.03.017 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejpn.2025.03.017 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1090379825000637 
|
| Verfasserangaben: | Ulrike Mütze, Svenja Scharré, Elena Schnabel-Besson, Oya Kuseyri Hübschmann, Friederike Höster, Ali Tunҫ Tuncel, Stefan Kölker, Thomas Opladen |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1938973046 | ||
| 003 | DE-627 | ||
| 005 | 20251021111715.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251021s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejpn.2025.03.017 |2 doi | |
| 035 | |a (DE-627)1938973046 | ||
| 035 | |a (DE-599)KXP1938973046 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Mütze, Ulrike |d 1979- |e VerfasserIn |0 (DE-588)135567963 |0 (DE-627)693593024 |0 (DE-576)279666438 |4 aut | |
| 245 | 1 | 0 | |a Newborn screening for neuro-metabolic disorders |b Strategies, clinical benefits, and prerequisites for program expansion |c Ulrike Mütze, Svenja Scharré, Elena Schnabel-Besson, Oya Kuseyri Hübschmann, Friederike Höster, Ali Tunҫ Tuncel, Stefan Kölker, Thomas Opladen |
| 264 | 1 | |c 24 April 2025 | |
| 300 | |b Tabellen | ||
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Frau Friederike Hörster wurde fälscherweise als "Höster" eingegeben | ||
| 500 | |a Gesehen am 21.10.2025 | ||
| 520 | |a Newborn screening (NBS) is a successful program of secondary prevention for rare diseases, such as neuro-metabolic diseases, enabling early identification of affected individuals and pre-symptomatic treatment. Driven by innovations in high-throughput sequencing technologies, NBS panels have continued to grow and will probably be extended further in the future. However, implementing NBS for a disease is subject to various preconditions to maximize the benefit for the affected children, while avoiding harm to the screened healthy cohort, their families and the society. Ideally, data on clinical long-term benefit of NBS and early treatment is collected prior to NBS implementation through long-term observational studies and registries. In addition, NBS should be implemented as an iteratively evaluated public health program and the data collection should be accompanied by intra-operable long-term observational studies, ideally extended in international cooperations. In this review, the current expertise in NBS, the screening strategies and possible long-term clinical benefits are presented and discussed for several neuro-metabolic diseases, including propionic acidemia and isolated methylmalonic acidemias, homocystinurias, remethylation defects, acquired cobalamin (vitamin B12) deficiency, urea cycle disorders, tetrahydrobiopterin (BH4) and primary neurotransmitter disorders, as well as lysosomal storage disorders. Given these prerequisites, several of the neuro-metabolic diseases discussed here might be part of future NBS programs worldwide. | ||
| 650 | 4 | |a Inborn error of metabolism | |
| 650 | 4 | |a Inherited metabolic diseases | |
| 650 | 4 | |a Long-term outcome | |
| 650 | 4 | |a Neonatal screening | |
| 650 | 4 | |a Newborn screening | |
| 700 | 1 | |a Scharré, Svenja |e VerfasserIn |0 (DE-588)1322650187 |0 (DE-627)1882604911 |4 aut | |
| 700 | 1 | |a Schnabel-Besson, Elena |d 1990- |e VerfasserIn |0 (DE-588)1222196808 |0 (DE-627)1741198224 |4 aut | |
| 700 | 1 | |a Kuseyri Hübschmann, Oya |d 1985- |e VerfasserIn |0 (DE-588)1038105617 |0 (DE-627)756673372 |0 (DE-576)392127156 |4 aut | |
| 700 | 1 | |a Hörster, Friederike |e VerfasserIn |0 (DE-588)1070020419 |0 (DE-627)823189155 |0 (DE-576)429699220 |4 aut | |
| 700 | 1 | |a Tuncel, Ali Tunç |d 1988- |e VerfasserIn |0 (DE-588)1075946069 |0 (DE-627)83405728X |0 (DE-576)444773339 |4 aut | |
| 700 | 1 | |a Kölker, Stefan |e VerfasserIn |0 (DE-588)1022937758 |0 (DE-627)717335771 |0 (DE-576)366197568 |4 aut | |
| 700 | 1 | |a Opladen, Thomas |d 1974- |e VerfasserIn |0 (DE-588)124489656 |0 (DE-627)642820481 |0 (DE-576)335321291 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of paediatric neurology |d [Oxford] : Elsevier, 1997 |g 56(2025) vom: Mai, Seite 84-96 |h Online-Ressource |w (DE-627)320475417 |w (DE-600)2009085-7 |w (DE-576)26776183X |x 1532-2130 |7 nnas |a Newborn screening for neuro-metabolic disorders Strategies, clinical benefits, and prerequisites for program expansion |
| 773 | 1 | 8 | |g volume:56 |g year:2025 |g month:05 |g pages:84-96 |g extent:13 |a Newborn screening for neuro-metabolic disorders Strategies, clinical benefits, and prerequisites for program expansion |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejpn.2025.03.017 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1090379825000637 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251021 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 124489656 |a Opladen, Thomas |m 124489656:Opladen, Thomas |d 910000 |d 910500 |d 50000 |e 910000PO124489656 |e 910500PO124489656 |e 50000PO124489656 |k 0/910000/ |k 1/910000/910500/ |k 0/50000/ | ||
| 998 | |g 1022937758 |a Kölker, Stefan |m 1022937758:Kölker, Stefan |d 50000 |d 910000 |d 910500 |e 50000PK1022937758 |e 910000PK1022937758 |e 910500PK1022937758 |k 0/50000/ |k 0/910000/ |k 1/910000/910500/ | ||
| 998 | |g 1075946069 |a Tuncel, Ali Tunç |m 1075946069:Tuncel, Ali Tunç |d 910000 |d 910500 |e 910000PT1075946069 |e 910500PT1075946069 |k 0/910000/ |k 1/910000/910500/ | ||
| 998 | |g 1070020419 |a Hörster, Friederike |m 1070020419:Hörster, Friederike |d 910000 |d 910500 |d 50000 |e 910000PH1070020419 |e 910500PH1070020419 |e 50000PH1070020419 |k 0/910000/ |k 1/910000/910500/ |k 0/50000/ | ||
| 998 | |g 1038105617 |a Kuseyri Hübschmann, Oya |m 1038105617:Kuseyri Hübschmann, Oya |d 910000 |d 910500 |e 910000PK1038105617 |e 910500PK1038105617 |k 0/910000/ |k 1/910000/910500/ | ||
| 998 | |g 1222196808 |a Schnabel-Besson, Elena |m 1222196808:Schnabel-Besson, Elena |d 910000 |d 910500 |e 910000PS1222196808 |e 910500PS1222196808 |k 0/910000/ |k 1/910000/910500/ | ||
| 998 | |g 1322650187 |a Scharré, Svenja |m 1322650187:Scharré, Svenja |d 910000 |d 910500 |e 910000PS1322650187 |e 910500PS1322650187 |k 0/910000/ |k 1/910000/910500/ | ||
| 998 | |g 135567963 |a Mütze, Ulrike |m 135567963:Mütze, Ulrike |d 910000 |d 910500 |d 50000 |e 910000PM135567963 |e 910500PM135567963 |e 50000PM135567963 |k 0/910000/ |k 1/910000/910500/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1938973046 |e 4790045277 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1938973046","name":{"displayForm":["Ulrike Mütze, Svenja Scharré, Elena Schnabel-Besson, Oya Kuseyri Hübschmann, Friederike Höster, Ali Tunҫ Tuncel, Stefan Kölker, Thomas Opladen"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"24 April 2025"}],"id":{"doi":["10.1016/j.ejpn.2025.03.017"],"eki":["1938973046"]},"language":["eng"],"physDesc":[{"noteIll":"Tabellen","extent":"13 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"subtitle":"Strategies, clinical benefits, and prerequisites for program expansion","title":"Newborn screening for neuro-metabolic disorders","title_sort":"Newborn screening for neuro-metabolic disorders"}],"person":[{"display":"Mütze, Ulrike","family":"Mütze","role":"aut","given":"Ulrike"},{"display":"Scharré, Svenja","family":"Scharré","given":"Svenja","role":"aut"},{"display":"Schnabel-Besson, Elena","given":"Elena","role":"aut","family":"Schnabel-Besson"},{"display":"Kuseyri Hübschmann, Oya","family":"Kuseyri Hübschmann","role":"aut","given":"Oya"},{"role":"aut","given":"Friederike","family":"Hörster","display":"Hörster, Friederike"},{"display":"Tuncel, Ali Tunç","family":"Tuncel","given":"Ali Tunç","role":"aut"},{"family":"Kölker","given":"Stefan","role":"aut","display":"Kölker, Stefan"},{"given":"Thomas","role":"aut","family":"Opladen","display":"Opladen, Thomas"}],"relHost":[{"recId":"320475417","disp":"Newborn screening for neuro-metabolic disorders Strategies, clinical benefits, and prerequisites for program expansionEuropean journal of paediatric neurology","origin":[{"dateIssuedDisp":"2003-","publisher":"Elsevier ; Harcourt","dateIssuedKey":"2003","publisherPlace":"[Oxford] ; Burlington, Mass."}],"id":{"zdb":["2009085-7"],"issn":["1532-2130"],"eki":["320475417"]},"part":{"year":"2025","pages":"84-96","volume":"56","extent":"13","text":"56(2025) vom: Mai, Seite 84-96"},"note":["Gesehen am 05.02.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"European Paediatric Neurology Society","role":"isb"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1997 -"],"language":["eng"],"title":[{"title_sort":"European journal of paediatric neurology","title":"European journal of paediatric neurology","subtitle":"ejpn ; official journal of the European Paediatric Neurology Society"}]}],"note":["Frau Friederike Hörster wurde fälscherweise als \"Höster\" eingegeben","Gesehen am 21.10.2025"]} | ||
| SRT | |a MUETZEULRINEWBORNSCR2420 | ||